Product Information
OXYBUTYNIN CL ER 15 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1169 per EA under NDC 62135050990. Its NADAC has been published 155 times since Jul 12, 2023.
Strength
15 mg/1
Manufacturer
Chartwell RX LLCNDC
62135050990
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078503On Market Since
3/1/2009
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 15 MG TABLET has been published 155 times since Jul 12, 2023, and over the history we have for it it has declined 26.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1169 per EA |
|---|---|
| All-time high | $0.1735 (Sep 13, 2023) |
| All-time low | $0.0936 (Apr 17, 2024) |
| 52-week high | $0.1456 |
| 52-week low | $0.1161 |
| Median price | $0.1334 |
| Average price | $0.1327 |
| Largest weekly change | +38.9% (May 22, 2024) |
| Weeks tracked | 155 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the OXYBUTYNIN CHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 15 MG TABLET, manufactured by Chartwell RX LLC, is $0.1169 per EA (NDC 62135050990), effective Jun 24, 2026.
How has the price of OXYBUTYNIN CL ER 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has declined 26.5%. It has been tracked across 155 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 15 MG TABLET?
Since Jul 12, 2023, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has ranged from a low of $0.0936 (Apr 17, 2024) to a high of $0.1735 (Sep 13, 2023), with a median of $0.1334 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 15 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OXYBUTYNIN CL ER 15 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures OXYBUTYNIN CL ER 15 MG TABLET?
OXYBUTYNIN CL ER 15 MG TABLET (NDC 62135050990) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification